Drug development target for retinal dystrophies
Researchers report that deleting one of the inhibitors of the RPE65 gene in a mouse model that carries a human disease mutation prevents degeneration of cone photoreceptors that are used for daytime high-resolution color vision.
Read Original Article: Drug development target for retinal dystrophies »
